Vaidya Sane Ayurved Laboratories Limited · NSE:MADHAVBAUG
Vaidya Sane Ayurved Laboratories — Investor Presentation (May 2024)
41 slides from Vaidya Sane Ayurved Laboratories's investor presentation, May 30, 2024
Slide 1: Cover letter to National Stock Exchange
Date: 30th May 2024 To, Listing Compliance Department, National Stock Exchange of India Limited, Exchange Plaza, Bandra Kurla Complex, Bandra East, Mumbai-400051 NSE Symbol: Madhavbaug Sub: Investor Presentation Please find attached Investor Presentation based on the Financial & operational performa
Slide 2: Investor Presentation May 2024
Vaidya Sane Ayurved Laboratories Ltd. Investor Presentation May 2024
Slide 3: Disclaimer
Disclaimer This presentation has been prepared by Vaidya Sane Ayurved Laboratories Limited (the “Company”) solely for information purposes and does not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in conn
Slide 4: Table of Contents
V a = of Contents a Company Overview foal (w) Business Overview Industry Overview (@) Financial Highlights Way Ahead Madhavbaug Multcisciolinary Cardiac Care Clinics & Hospitals
Slide 5: Company Overview
Company Overview aes = 2s
Slide 6: About Us
About Us Among leading chains of Cardiac care clinics & Hospitals Unique medical service institution – focus on Traditional Medicine Strives to reduce India’s disease burden of Cardiac disease, Diabetes, Hypertension and Obesity Madhavbaug has 353* Clinics Across India Treatments Rural reach
Slide 7: Company Structure
Company Structure F-Health Accelerators Pvt. Ltd. Cure & Care Primary Care Pvt. Ltd. Easy Ayurveda Pvt. Ltd. 01 (80% Holding) 02 (Raphacure – 17.5% Holding) 03 (15% Holding) Shareholding Agreement with Dr. Focus on start-ups that work in the Shareholding Agreement with Cure and Janardhana V He
Slide 8: Madhavbaug's 360 Degree Ecosystem
Madhavbaug’s 360 Degree Ecosystem Holistic Treatment Methodology leading to objective results Assessment & Screening Using Modern Diagnostics to provide accurate results - ECG, Stress Test, 2D Echo, Blood Investigations, CT Researched diets, tested lifestyle modifications Angiography etc. techniques
Slide 9: Journey So Far
Journey So Far Listing of shares on NSE-Emerge Khopoli Hospital empanelment with SBI General 2018 - India book record Insurance 2006 - 1st Cardiac 2014 - Arogyam Hriday for conducting GTT of 661 NABH of Madhavbaug Khopoli Hospital Hospital in Khopoli Sampada launched patient in single da
Slide 10: Strong & Experienced Management
Strong & Experienced Management Dr. Rohit Sane MBBS (Medicine and Surgery) and fellowship in Cardiac Rehabilitation (Chairman & More than 20 years of experience in health care consulting Managing Director ) Pioneer in conceptualizing and promoting Ayurveda in healing of chronic heart diseases
Slide 11: Strong & Experienced Management
Strong & Experienced Management BAMS, MD (Samhita, Siddhant), PGDEMS and Certified Black belt in Six Sigma Affiliated with Madhavbaug since 2007, worked on various levels in medical operations, and Dr. Gurudatta Amin Designated as CMO since 2012 (Chief Medical Officer) Designed Medical Strateg
Slide 12: Key Strengths
Key Strengths Strong Research based Treatments & Therapies with papers published and accepted internationally Unique combination of modern healing methods and ancient natural practices Experienced Leadership with able & well-trained team led by Dr. Rohit Madhav Sane Effective, Non- Invasive & Afford
Slide 13: Business Overview
~ 02 Business Overview
Slide 14: Madhavbaug's Unique Model
Madhavbaug’s Unique Model Business Clinic Revenue Model Model FY24 Revenue: Rs. 149.08 Cr Hospitals Clinics Services Products *Revenue : Rs. 33.59 Cr *Revenue : Rs. 149.08 Cr *Revenue : Rs. 85.64 Cr *Revenue : Rs. 63.44 Cr Hospitals, Products, 18.39% Clinics, 42.55% 81.61% Services, 57.45% *
Slide 15: Holistic Treatment Programs
Holistic Treatment Programs Secondary Prevention & Rehabilitation Programs: Plaque Stabilization Therapy (PST) Treatment Programs Diabetic Complication Management (DHCM) Heart Failure Reversal Therapy (HFRT) Hypertensive Complication Management (HCM) Ischemia Reversal Programme (IRP) Tot
Slide 16: …with Innovative Reversal Therapies…
…with Innovative Reversal Therapies… Heart Disease Diabetes Blood Pressure Obesity Reversal Reversal Management Management Cardioprotective Therapy Comprehensive Diabetic Care Blood Pressure Management Obesity Management Ischemic Reversal Program Program Program Program CAD Management
Slide 17: …with Pan India Network as on 31st March 2024
…with Pan India Network as on 31st March’ 2024 States No. of Clinics Jammu and Kashmir 1 Punjab 5 Haryana 3 Uttarakhand 2 Delhi NCR 4 Uttar Pradesh 18 Rajasthan 2 Madhya Pradesh 18 West Bengal 2 Orissa 1 Chhattisgarh 4 Gujarat 17 Goa 4 Maharashtra 251 Madhavbaug Hospital Khopoli, Karnataka 21 Madhav
Slide 18: State of Art Hospitals - Khopoli & Nagpur, Maharashtra
State of Art Hospitals - Khopoli & Nagpur, Maharashtra Khopoli Hospital (Revenue in Rs. Cr) Madhavbaug Hospital Khopoli – 1st Hospital in 2006 Madhavbaug Hospital Kondhali, Nagpur – 2nd Hospital in 2012 26.42 Madhavbaug Vizag Hospital – Vishakhapatnam – 3rd Hospital in 2023 – 22.77 Generates R
Slide 19: Multidisciplinary Cardiac Care Clinics
Multidisciplinary Cardiac Care Clinics 18
Slide 20: Multidisciplinary Cardiac Care Clinics
Multidisciplinary Cardiac Care Clinics No. of Clinics (Ownershipwise) Average Revenue per Clinic (Rs. in Lacs) Clinic Enterprise Revenue (In Rs. Lacs) No. of Patient - Total Footfall 353 49.19 8,02,6 302 9,025 8,564 97 277 249 6,542 6,259 6,344 178 196 7,80,4 43.21 4,909 42.23 62 48 51 49 57 42 62 F
Slide 21: Empanelment with Insurance Companies
Empanelment with Insurance Companies Medi Assist Ericson Insurance TPA Health India Paramount Health More than 30 Insurance companies empaneled with above Third Party Administrators (TPA) each 20
Slide 22: Madhavbaug POWER MAP
Madhavbaug POWER MAP Medical analytics service built for Madhavbaug Doctors to help them reverse Chronic cardiac disease of their patients effectively - Union Minister for Road Transport and Highways Nitin Gadkari inaugurated Madhavbaug's Power MAP on 15th January 2022 Critical Care Diet Man
Slide 23: mib Pulse App - Enable Healthcare reach to lowest strata
mib Pulse App - Enable Healthcare reach to lowest strata It’s a free app which anyone can use from anywhere in case of Medical assistance App gives you full past history of your health MIB Pulse App (+100K Downloads) Medical Assistance Connected Medical Assistance of Doctors to give patients
Slide 24: Madhavbaug's Research based Diet Kits
Madhavbaug’s Research based Diet Kits Diabetes Reversal Heart Disease Reversal Hypertension Reversal Obesity Reversal Breakfast Lunch/Dinner 23
Slide 25: Industry Overview
03 Industry Overview
Slide 26: India's Non-Communicable Disease (NCD) Challenges
India’s Non – Communicable Disease (NCD) Challenges 66% of all death in India caused by Non – Communicable diseases Roughly 77 million Diabetes patients in India India estimated to have 44 million Diabetes 1 million Indians die of Diabetes p.a undiagnosed Diabetes patients India has 135 millio
Slide 27: Higher Stress increasing Diseased population
Higher Stress increasing Diseased population Middle Class Population ( In million) 800.0 400.0 153.0 2010 2020 2030 Working Age Population of India (in million) 665.0 Share of Non-communicable diseases 574.0 463.0 495.0 – Causes of death, India, 2000-22 397.0 62.0% 66.0% 68.0% 70.0% 56.0% 46.0% 2000
Slide 28: Re-emergence of Traditional Medical Care
Re-emergence of Traditional Medical Care Notable trends Market size and services offered Traditional medical sector developing Traditional Knowledge Digital Indian Ayurvedic Industry expected to reach Library to prevent companies from claiming patents on such remedies US$ 9 billion by 2022 - Ayu
Slide 29: Financial Highlights
04 Financial Highlights
Slide 30: Management Comments
Management Comments “During the year we have registered a Revenue of Rs. 99.33 crore. EBITDA and PAT were Rs. 4.50 crore and 1.99 crore. Sales towards non disease patients coupled with successful marketing campaign helps to maintain revenue level. In FY24 we successfully treated 38,212 patients thro
Slide 31: Strategic Maneuver in H2 FY 2024
Strategic Maneuver in H2 FY 2024 Following are the major strategic maneuver or action plans, devised during the H2 FY 2024, which shall be apparent in FY 2024-25 and onwards - Employee Benefits cost not to outrun above 22% of Sales of the company - Consumption Cost to be brought down to 25-26% from
Slide 32: Consolidated Half Yearly Financial Highlights
Consolidated Half Yearly Financial Highlights Enterprise Collection (Rs. Cr) Revenue (Rs. Cr) VSAL Clinics & OPD and Mini Clinics Khopoli Hospital 53.58 51.10 Kondhali Hospital Vizag Hospital 48.23 85.18 43.15 45.59 77.94 31.36 11.87 14.23 3.55 0.00 3.79 0.08 H2 FY23 H2 FY24 H1 FY22 H2 FY22 H1 FY23
Slide 33: Consolidated Financial Highlights – Half Yearly
Consolidated Financial Highlights – Half Yearly Rs. Crore H2 FY24 H2 FY23 Y-o-Y (%) H1 FY24 Income from Operations 48.23 53.58 51.10 Other Operating Income 0.00 0.00 0.00 Revenue from operations for H2 FY24 is Total Income 48.23 53.58 (9.99%) 51.10 Raw Materials 10.77 14.56 14.93 48.23 crs as agai
Slide 34: Annual Financial Highlights
Annual Financial Highlights Enterprise Collection (Rs. Cr) Revenue (Rs. Cr) VSAL Clinics & OPD and Mini Clinics Khopoli Hospital Kondhali Hospital Vizag Hospital 99.17 99.33 157.95 149.00 75.23 74.71 114.70 52.27 19.00 23.00 26.42 5.00 0.00 7.00 0.00 7.09 0.08 FY22 FY23 FY24 FY20 FY21 FY22 FY23 FY24
Slide 35: Consolidated Financial Highlights – Annual
Consolidated Financial Highlights – Annual Rs. Crore FY24 FY23 Y-o-Y (%) Income from Operations 99.33 99.17 Other Operating Income 0.00 0.00 Revenue from operations for FY24 is Total Income 99.33 99.17 0.16% 99.33 crs as against Rs. 99.17 crs in FY23, Raw Materials 25.71 27.62 YoY increase of 0.16
Slide 36: Consolidated Annual Balance Sheet Highlights
Consolidated Annual Balance Sheet Highlights As on 31st As on 31st As on 31st As on 31st Rs. Crore Rs. Crore Mar’ 24 Mar’ 23 Mar’ 24 Mar’ 23 Shareholder’s Funds 55.60 40.45 Non-current assets 37.43 27.10 Share capital 10.51 10.51 Property, Plant & Equipment Other Equity 31.66 29.94 Tangible assets 2
Slide 37: Key Balance Sheet Ratios
Key Balance Sheet Ratios RoE(%) RoA(%) 8.80% 11.94% 9.67% 6.94% 4.02% 3.56% 2.79% 1.52% 1.30% 0.42% FY20 FY21 FY22* FY23 FY24 FY20 FY21 FY22* FY23 FY24 RoCE(%) 17.76% 15.44% 16.95% 7.66% 5.53% FY20 FY21 FY22* FY23 FY24 * IPO in FY22 to raise Rs. 20.23 crs 36 RoE = Net Profit/Net Worth | RoA = Net Pr
Slide 38: Way Ahead
a y Way Ahead oe
Slide 39: Way Ahead
Way Ahead Scalable and Standardized Clinic Design Clinic-based health care delivery model along with tele-medicine - low capex requirement and easy accessibility Strengthening and Expanding Clinic and Hospital Network Strategic locations in Maharashtra; expand Clinic Network in Madhya Pradesh, U
Slide 40: Madhavbaug's Mission 2028
Madhavbaug’s Mission 2028 “By 2028, Over 5 Crore People in India will be directly under Madhavbaug’s Care” Clinics & Hospitals Expansion of Khopoli hospital with 60 Save My Heart – App Beds and Kondhali 20 Beds additional Purported for preventation Cashless services to patients at hospitals of
Slide 41: Thank You
THANK YOU For further information, please contact: Mr. Abhishek Deshpande Mr. Amit Sharma / Mr. Rupesh Rege Vaidya Sane Ayurved Laboratories Ltd AdfactorsPR Pvt. Ltd. Tel: +91 9764434693 Tel: +91 98677 26686 /+91 9594918891 Email: cs@Madhavbaug.com Email: amit.sharma@adfactorspr.com/rupesh.rege@adfa
Vaidya Sane Ayurved Laboratories — Investor Presentation (May 2024) on 6ix